Tennis Integrity International

The International Tennis Integrity Agency (ITIA) is an independent body established in 2021 by the International Governing Bodies of Tennis to promote, encourage, enhance and safeguard the integrity of tennis worldwide.

Funded by the sport’s seven major stakeholders - the International Tennis Federation, ATP, WTA, Australian Open, French Open, Wimbledon and the US Open.

The ITIA promotes, encourages and safeguards the integrity of professional tennis worldwide by:

Preventing corruption and doping from taking place
Investigation and prosecution of offenders
Delivering anti-corruption and anti-doping education for players and stakeholders, to recognise and report dishonest activity.

The Testing Process

Athletes can be tested any time, any place.

We test to deter those vulnerable to a doping decision and to find those who chose to cheat by using banned substances.

Testing can take place in-competition at events, or out-of-competition, in training venues, or even at an athlete’s home.

Testing is intelligence-led and risk-based, however it will always be conducted with ‘no advanced notice’.

Athletes can be tested any time, any place.
We test to deter those vulnerable to a doping decision and to find those who chose to cheat by using banned substances.
Testing can take place in-competition at events, or out-of-competition, in training venues, or even at an athlete’s home.
Testing is intelligence-led and risk-based, however it will always be conducted with ‘no advanced notice’.

Testing Process for Minors

As an athlete under the age of 18, you are considered a minor. You may not be aware, but you can still be tested.

Much of the testing process is the same as older athletes, however modifications are made to ensure minors are safeguarded.  

Testing Process for Athletes with an Impairment

For those athletes with an impairment such as physical, visual or intellectual there are some modifications to the testing process to ensure it is accessible and suitable for all.

Athlete Biological Passport (ABP)

A selected group of tennis players are tested regularly as part of the Athlete Biological Passport (ABP) Programme. ABPs are used across tennis and other sports to determine whether players are using prohibited substances or methods.

Traditional anti-doping testing aims to directly identify prohibited substances and methods in an athlete’s blood and urine.

The ABP allows the long-term monitoring of an athlete’s biological data in both blood and urine, looking indirectly for potential markers that indicate doping within a set of parameters, called biomarkers.

A player’s ABP profile, or ‘passport’, is made up of multiple blood and urine samples collected and analysed over time. The analysis of these samples allows for a player’s normal values to be established.

These normal values are monitored long-term for changes; such changes can be caused by the following:

The use of a prohibited substance or method without detecting the substance in traditional Anti-Doping tests.
Irregular use of prohibited substances and methods.
Use of substances for which a direct test is not available.

Players have access to their ABP sample record on ADAMS at all times should they want to view their personal data.

ABP data/monitoring is managed and handled anonymously by an external Athlete Passport Management Unit (APMU), which are WADA-accredited laboratories. If an APMU suspects the use of prohibited substances or methods, the passport is sent for further analysis by three independent experts.

The ABP approach was officially introduced by WADA in 2009 and operates amongst International Federation (IF) and National Anti-Doping Agency (NADO) programmes worldwide.

For more information on ABPs, visit WADA’s website.

Address

ITIA, Bank Lane
Roehampton, London
SW15 5XZ
United Kingdom

General Enquiries

** https://www.itia.tennis